Merck & Co., Inc. is a global healthcare company that offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, which it markets directly and through its joint ventures. The company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions.
Merck systematically reduces its environmental impact by setting emissions reductions targets and applying Green Chemistry principles in its research and manufacturing operations. In particular, the company minimizes solvent use—a primary of contributor of air emissions for pharmaceutical companies—by integrating life-cycle analyses and green chemistry into its product design process while utilizing recovered solvents when appropriate. Merck also audits the environmental management systems of its suppliers every two to three years. In terms of its access to health care strategy, the company takes a holistic approach through a number of initiatives and policies that seek to provide underserved communities with affordable treatments and build local capacity to drive sustained improvements. Specifically, Merck has a pipeline of drugs that address diseases endemic to developing nations such as HIV, diabetes, and Neglected Tropical Diseases; tiered pricing strategies; substantial licensing agreements; and several capacity building initiatives (e.g. Vietnam, India, and Ethiopia). The company also offers strong benefits packages and training opportunities to its employees, including stock options, flexible spending accounts and education assistance programs.
Merck faces ongoing product safety and gender discrimination litigation. Additionally, despite a comprehensive anti-corruption policy that applies to all of the company’s business partners, Merck fails to monitor compliance of its third-party intermediaries.
Industry: Health Care
Country: United States
To the best of our knowledge the above information is accurate and was obtained from sources we believe to be reliable. Neither the information presented above nor any opinion expressed shall be construed as an offer to sell or a solicitation to buy the security. The views expressed are those of portfolio management as of 12/31/16 and may not reflect current opinions or subsequent events.